Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients. Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, et al. Aliment Pharmacol Ther 2020;51:719-727.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, et al. Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients. Aliment Pharmacol Ther 2020;51:719-727.
PMID: 32080886